Ralph A. Tripp
22Patents
6h-index
25Co-inventors
69Inventor score
Filing activity: Jan 14, 2000 → Oct 12, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7738096B2 | Surface enhanced Raman spectroscopy (SERS) systems, substrates, fabrication thereof, and methods of use thereof | Physics | 28 | Active |
| US7371392B2 | Cd40 ligand adjuvant for respiratory syncytial virus | Chemistry; Metallurgy | 24 | Expired |
| US7583379B2 | Surface enhanced raman spectroscopy (SERS) systems and methods of use thereof | Physics | 23 | Active |
| US7940387B2 | Surface enhanced Raman spectroscopy (SERS) systems for the detection of viruses and methods of use thereof | Chemistry; Metallurgy | 9 | Active |
| US8173131B2 | Compositions and methods for modulating RSV infection and immunity | Chemistry; Metallurgy | 8 | Expired |
| US7880876B2 | Methods of use for surface enhanced raman spectroscopy (SERS) systems for the detection of bacteria | Physics | 8 | Active |
| US7889334B2 | Surface enhanced Raman spectroscopy (SERS) systems for the detection of bacteria and methods of use thereof | Physics | 4 | Active |
| US10137188B2 | Cell lines for virus production and methods of use | Chemistry; Metallurgy | 2 | Active |
| US11118166B2 | Production of viruses in avian eggs | Emerging Cross-Sectional Technologies | 1 | Active |
| US10907133B2 | Production of viruses in avian eggs | Emerging Cross-Sectional Technologies | 1 | Active |
| US10626379B2 | Production of viruses in cell culture | Chemistry; Metallurgy | 1 | Active |
| US11174466B2 | Production of viruses in cell culture | Chemistry; Metallurgy | 1 | Active |
| US11116737B1 | Methods of using probenecid for treatment of coronavirus infections | Human Necessities | 1 | Active |
| US8846056B2 | Anti-RSV immunogens and methods of immunization | Chemistry; Metallurgy | 1 | Active |
| US8354115B2 | CD40 ligand adjuvant for respiratory syncytial virus | Chemistry; Metallurgy | 0 | Active |
| US10883086B2 | Methods and compositions related to increased influenza virus production | Chemistry; Metallurgy | 0 | Active |
| US7101547B1 | Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies | Chemistry; Metallurgy | 0 | Expired |
| US8771706B2 | Anti-RSV immunogens and methods of immunization | Chemistry; Metallurgy | 0 | Active |
| US11903916B2 | Methods of using probenecid for treatment of coronavirus infections | Human Necessities | 0 | Active |
| US8778354B2 | Compositions and methods for modulating RSV infection and immunity | Chemistry; Metallurgy | 0 | Active |
| US11655471B2 | Engineered cells with decreased gene expression resulting in increased viral production | Emerging Cross-Sectional Technologies | 0 | Active |
| US12054750B2 | Production of viruses in cell culture | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.